Matches in Nanopublications for { ?s ?p "[The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP163530.RAmhQc_yr_0_UyEhi7EbpbfSd-157TGfR0mZD7K0642dQ130_assertion description "[The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP163530.RAmhQc_yr_0_UyEhi7EbpbfSd-157TGfR0mZD7K0642dQ130_provenance.
- NP63432.RAezkLTk5vneMi6bmiYD00qCiLZWsdUiOYlxZddJDoKFM130_assertion description "[The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP63432.RAezkLTk5vneMi6bmiYD00qCiLZWsdUiOYlxZddJDoKFM130_provenance.
- assertion description "[The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP692107.RAAtcMReWo67u-kRDZMxZz1g2tAY6SjXdsn35aJi8ejFg130_assertion description "[The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692107.RAAtcMReWo67u-kRDZMxZz1g2tAY6SjXdsn35aJi8ejFg130_provenance.
- NP129716.RAg4n-Y3W1sZOIjvpH8_u1a-3M18nm8K-g976vcdkp12U130_assertion description "[The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP129716.RAg4n-Y3W1sZOIjvpH8_u1a-3M18nm8K-g976vcdkp12U130_provenance.
- NP692106.RAl2hwedd3tceUBsiPWFOCfw5Sogm8Z-oXgLTFZV7bT0w130_assertion description "[The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692106.RAl2hwedd3tceUBsiPWFOCfw5Sogm8Z-oXgLTFZV7bT0w130_provenance.